Kalein Tablet (Kalidinoegenase)

Adult dose

Administer 30-150 I.U. per day orally in 3 divided doses. Adjust the dose as appropriate according to age and symptoms.

This medicine should not be used in patients with bleeding conditions such as immediately after a cerebral hemorrhage. Additionally, since this medication contains lactose, it should not be administered to patients with genetically determined galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. When using this medication, allergic reactions may occur, so it is essential to discontinue use immediately if skin rash or itching develops. There is also a rare possibility of symptoms such as rapid heartbeat, requiring caution. Gastrointestinal symptoms may arise, including discomfort in the stomach, nausea, vomiting, loss of appetite, abdominal pain, diarrhea, or constipation. Furthermore, there can be rare occurrences of fever, headache, heaviness in the head, drowsiness, or fatigue, so monitor the condition closely. In elderly patients, physical functions may be decreased, so the dose should be reduced or used with special caution.

• Rash
• itching
• palpitations
• abdominal discomfort
• nausea
• vomiting
• loss of appetite
• upper abdominal pain
• diarrhea
• constipation

This medication should be stored in a sealed container to prevent air from entering, and it is recommended to keep it at room temperature between 1 degree and 30 degrees. Proper storage will help maintain the effectiveness of the medication for a long time.

Appearance

White, round enteric-coated film-coated tablet

Package unit

30/bottle, 300 tablets/bottle